Gene Expression Patterns in Ovarian Carcinomas
- 1 November 2003
- journal article
- research article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 14 (11) , 4376-4386
- https://doi.org/10.1091/mbc.e03-05-0279
Abstract
We used DNA microarrays to characterize the global gene expression patterns in surface epithelial cancers of the ovary. We identified groups of genes that distinguished the clear cell subtype from other ovarian carcinomas, grade I and II from grade III serous papillary carcinomas, and ovarian from breast carcinomas. Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas (predominantly serous papillary) based on their gene expression patterns. The differences may yield insights into the worse prognosis and therapeutic resistance associated with clear cell carcinomas. A comparison of the gene expression patterns in the ovarian cancers to published data of gene expression in breast cancers revealed a large number of differentially expressed genes. We identified a group of 62 genes that correctly classified all 125 breast and ovarian cancer specimens. Among the best discriminators more highly expressed in the ovarian carcinomas were PAX8 (paired box gene 8), mesothelin, and ephrin-B1 (EFNB1). Although estrogen receptor was expressed in both the ovarian and breast cancers, genes that are coregulated with the estrogen receptor in breast cancers, including GATA-3, LIV-1, and X-box binding protein 1, did not show a similar pattern of coexpression in the ovarian cancers.Keywords
This publication has 68 references indexed in Scilit:
- Modulation of alternative pre-mRNA splicing in vivo by pininBiochemical and Biophysical Research Communications, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Clear Cell Ovarian Carcinoma Following Long‐Term Tamoxifen UseThe Breast Journal, 1999
- Immunohistochemical Characterization of 22 Monoclonal Antibodies against the CA125 Antigen: 2nd Report from the ISOBM TD-1 WorkshopTumor Biology, 1996
- Preoperative CA 125: An Independent Prognostic Factor in Patients With Stage I Epithelial Ovarian CancerObstetrics & Gynecology, 1995